πŸ‡ΊπŸ‡Έ FDA
Patent

US 9738641

Bicyclic inhibitors

granted A61KA61K31/5365A61P

Quick answer

US patent 9738641 (Bicyclic inhibitors) held by KalVista Pharmaceuticals Limited expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KalVista Pharmaceuticals Limited
Grant date
Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/5365, A61P, A61P1/04, A61P1/18